← brief for 2026-09-28 · Slowing decline

Dapagliflozin Alone or Combined With Semaglutide: Cardiovascular and Renal Outcomes Among Patients With Type 2 Diabetes Mellitus in a 6-Month Real-World Retrospective Cohort Study in Saudi Arabia.

Article C Peer reviewed Observational

Key takeaways

This study looked at 539 people with type 2 diabetes. It compared one diabetes drug to a combination of two drugs. It checked heart and kidney health. It shows a link between the treatments and health outcomes, but it is not proof of cause.

Who did this work

Alharajin R · AlTaweel M · AlSubaiee M · Al Makhloof S · Almusaad A · Alarfaj A · AlKhayyal A · Altharman N · Alalawi A · Almannai N · Alohaymid M · Alsaad A

Source

Article · PubMed, the drug frontier · 2026 Aug 13
https://pubmed.ncbi.nlm.nih.gov/42802824/